ANTIPLATELET DRUG TOXICITY

Course overview

ANTIPLATELET MEDICATIONS ARE PRIMARILY USED FOR THE MANAGEMENT AND PREVENTION OF CARDIOVASCULAR DISEASE (CVD) RELATED EVENTS. CURRENTLY, THERE ARE FOUR CLASSIFICATIONS OF THESE AGENTS BASED UPON THE MECHANISM OF ACTION UTILIZED, BUT ALL INHIBIT PLATELET ACTIVATION AND AGGREGATION ULTIMATELY. THIS ACTIVITY REVIEWS THE INDICATIONS AND ACTIONS OF THESE MEDICATIONS, AS WELL AS THE TREATMENT OF TOXIC EXPOSURE TO THEM. THE TOXICOKINETICS, ADVERSE EVENT PROFILE, AND SPECIFIC MANAGEMENT OF THESE AGENTS WILL BE HIGHLIGHTED FOR THE EDIFICATION OF THE INTERPROFESSIONAL HEALTHCARE TEAM WHEN EMPLOYING ANTIPLATELET THERAPY TO PATIENTS.